News

AroCell TK 210 ELISA can now be used on automated platforms

Oct 28, 2020

Quantification of Thymidine Kinase 1 in serum with AroCell TK 210 ELISA is now validated for use on an open automation platform for ELISA. This enhances the application and use of the assay.

We have now validated AroCell TK 210 ELISA for use on an automation platform, the Crocodile 5-in-1 ELISA mini workstation. This confirms that our product can both be used in manual operation as well as in automated operation mode. AroCell TK 210 ELISA shows similar high performance in terms of precision and sensitivity when used in this automated system as when run in manual mode, providing maximum flexibility for our customers.

Using AroCell TK 210 ELISA on an automation platform makes it easier than ever to measure levels of Thymidine kinase 1 (TK1) in blood samples (serum or Lithium-heparin plasma) for clinical use or in cell culture and xenografts models during drug development. AroCell TK 210 ELISA measures the concentration of TK1 by immunoassay and detects both active and inactive TK1, does not cross-react with TK2, or with non-human TK1.

Read more about AroCell TK 210 ELISA

Thesis projects at IDL Diagnostics.

We are pleased to recognize four outstanding students who have recently completed their thesis projects with us at IDL Diagnostics. The projects started in January 2025. Putri Rezqita and Yu Shi from Karolinska Institutet contributed their deep knowledge in health and...

read more

EAU 2025

We attended the European Association of Urology #EAU25 in Madrid last weekend. Many valuable insights and great discussion with urologists from all over the world on the latest urology practice and how our products can contribute in improving cancer care. #EAU25 is...

read more